CRVO
CervoMed Inc.
NASDAQ: CRVO · HEALTHCARE · BIOTECHNOLOGY
$3.69
+1.10% today
Updated 2026-04-30
Market cap
$35.92M
P/E ratio
—
P/S ratio
8.97x
EPS (TTM)
$-2.98
Dividend yield
—
52W range
$4 – $12
Volume
0.1M
CervoMed Inc. (CRVO) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $308761.00 | $40189.00 | — | $40189.00 | $570476.00 | $374542.00 | $71667.00 | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $7.14M | $9.74M | $4.01M |
| Revenue growth (YoY) | — | — | -87.0% | -100.0% | — | +1319.5% | -34.3% | -80.9% | -100.0% | — | — | — | — | — | — | — | — | — | +36.3% | -58.9% |
| Cost of revenue | — | $134148.00 | $24679.00 | $47204.00 | $210393.00 | $2.31M | $235803.00 | $675757.00 | $566262.00 | $8268.00 | $25342.00 | $67981.00 | $110371.00 | $97915.00 | $103168.00 | $93416.00 | $1.34M | $8.44M | $18.80M | — |
| Gross profit | — | $174613.00 | $15510.00 | $-47204.00 | $-170000.00 | $-1.74M | $138739.00 | $-604000.00 | $-566000.00 | $-8268.00 | $-25342.00 | $-67981.00 | $-110000.00 | $-97915.00 | $-103168.00 | $-93416.00 | $-1.34M | $-1.29M | $-9.06M | — |
| Gross margin | — | 56.6% | 38.6% | — | -423.0% | -304.7% | 37.0% | -842.8% | — | — | — | — | — | — | — | — | — | -18.1% | -93.0% | 0.0% |
| R&D | — | — | — | — | — | — | — | — | $2.86M | $3.88M | $6.25M | $5.09M | $5.75M | $6.62M | $9.43M | $8.50M | $7.24M | $8.44M | $18.80M | $21.82M |
| SG&A | — | — | $950751.00 | — | $6.77M | $10.01M | $6.70M | — | — | — | — | — | — | $5.42M | $6.44M | $7.45M | $8.74M | $6.52M | $9.17M | $10.48M |
| Operating income | $-41900.00 | $-2.88M | $-2.22M | $-2.95M | $-7.64M | $-16.43M | $-11.79M | $-7.91M | $-7.34M | $-6.41M | $-14.87M | $-11.35M | $-12.03M | $-11.55M | $-15.97M | $-24.68M | $-15.97M | $-7.81M | $-18.23M | $-28.29M |
| Operating margin | — | -934.1% | -5528.9% | — | -19002.7% | -2879.9% | -3148.4% | -11039.9% | — | — | — | — | — | — | — | — | — | -109.3% | -187.2% | -706.2% |
| EBITDA | $-41900.00 | $-2.45M | $-1.15M | $-3.23M | $-8.28M | $-22.48M | $-6.52M | $-1.55M | $-16.33M | $-6.40M | $-18.35M | $566010.00 | $-18.70M | $-11.37M | $-15.76M | $-15.94M | $-3.48M | $-7.81M | $-18.23M | $-28.29M |
| EBITDA margin | — | -792.2% | -2866.5% | — | -20600.2% | -3941.4% | -1740.3% | -2168.4% | — | — | — | — | — | — | — | — | — | -109.3% | -187.2% | -706.2% |
| EBIT | $-41900.00 | $-2.50M | $-1.21M | $-3.28M | $-8.33M | $-22.60M | $-6.55M | $-2.23M | $-16.90M | $-6.41M | $-18.37M | $498029.00 | $-18.81M | $-11.47M | $-15.86M | $-16.04M | $-15.97M | $-2.17M | $-16.29M | — |
| Interest expense | $6196.00 | $162161.00 | $186489.00 | $122917.00 | $81389.00 | $30535.00 | $167894.00 | $228294.00 | $273503.00 | $313117.00 | $29686.00 | $2.92M | — | — | — | — | $587.00 | $0.00 | — | — |
| Income tax | — | — | $2.09M | — | — | — | — | — | $-2.82M | — | $-365000.00 | $-1.06M | $-437000.00 | $332885.00 | $-1.68M | $-443893.00 | $-3.48M | $800005.00 | — | — |
| Effective tax rate | 0.0% | 0.0% | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 16.4% | 0.0% | 2.0% | 43.6% | 2.3% | -2.9% | 10.6% | 1.8% | 18.2% | -58.3% | 0.0% | 0.0% |
| Net income | $-48096.00 | $-2.67M | $-2.09M | $-3.40M | $-8.41M | $-22.64M | $-6.87M | $-2.46M | $-14.35M | $-6.72M | $-18.04M | $-1.36M | $-18.37M | $-11.80M | $-14.19M | $-24.10M | $-15.59M | $-2.17M | $-16.29M | $-26.97M |
| Net income growth (YoY) | — | -5443.1% | +21.5% | -62.5% | -147.3% | -169.2% | +69.7% | +64.1% | -482.5% | +53.2% | -168.4% | +92.4% | -1245.8% | +35.8% | -20.2% | -69.9% | +35.3% | +86.1% | -650.1% | -65.5% |
| Profit margin | — | -863.5% | -5207.9% | — | -20926.1% | -3967.9% | -1834.0% | -3438.1% | — | — | — | — | — | — | — | — | — | -30.4% | -167.3% | -673.1% |